title: Chronic beneficial effects of type 1 angiotensin II receptor antagonist in patients with chronic hypoxemic pulmonary diseases.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Ogawa
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Hirose
authors.forename: Masaro
authors.initials: M
authors.lastname: Ogimoto
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Matsuki
authors.forename: Koichiro
authors.initials: K
authors.lastname: Miki
authors.forename: Masaru
authors.initials: M
authors.lastname: Kinoshita
authors.forename: Akitoshi
authors.initials: A
authors.lastname: Koga
authors.forename: Keiijro
authors.initials: K
authors.lastname: Saku
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D009320:Atrial Natriuretic Factor / Q000097:blood*; D005260:Female; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*
chemical_list: D000889:Anti-Arrhythmia Agents; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor; D019808:Losartan